SCHEMBL26575

SCHEMBL26575

[CH2]c1ccc(O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28500667 0.96
SCHEMBL3727100 0.90 ESR1 (0.69)
SCHEMBL1456756 0.83 MEN1 (0.74)
Hydroquinone SCHEMBL18095025 0.79 HSD17B10 (0.80)
Hydroquinone SCHEMBL11511669 0.78 ALOX15 (1.00)
Hydroquinone SCHEMBL15516 0.78
SCHEMBL147275 0.78
Hydroquinone SCHEMBL460669 0.78 ALOX15 (1.00)
Hydroquinone SCHEMBL730505 0.75 MAPT (0.73)
Hydroquinone SCHEMBL11222941 0.75 MAPT (0.73)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13835 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118359514-A N-ester salicylamide compound and preparation method and application thereof 湖南科技大学 2024-07-19 CN claimed
WO-2024151843-A1 TARGETED UNIVERSAL DELIVERY SYSTEM OF DON AND OTHER DRUGS THE JOHNS HOPKINS UNIVERSITY (US) 2024-07-18 WO claimed
CN-118344278-A Rosin amino acid compound and preparation method and application thereof 广西中医药大学 2024-07-16 CN claimed
US-20240226313-A1 CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF SEAGEN INC. 2024-07-11 US claimed
CN-118307501-A Dihydrophenanthropyrrole compound, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-07-09 CN claimed
US-20240218022-A1 ANTI-VISTA MACROCYCLIC PEPTIDES AND COMPOSITIONS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-07-04 US claimed
US-20240216420-A1 HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF SEAGEN INC (US) 2024-07-04 US claimed
CN-115785655-B Super-black weather-resistant polyamide material and preparation method and application thereof 上海中镭新材料科技有限公司 2024-07-02 CN claimed
US-20240207253-A1 Inhibitors of CDR1 for Reversal of Azole Drug Resistance in Fungal Infections THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-06-27 US claimed
US-20240197666-A1 DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) K-GEN THERAPEUTICS, INC. (US) 2024-06-20 US claimed
US-4072576-A Method for studying enzymatic and other biochemical reactions AB KABI (SW) 1978-02-07 US claimed
US-4060687-A Cephalosporins having a 3-α substituted alkyl grouping MERCK & CO., INC. (US) 1977-11-29 US claimed
US-4041041-A FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERRELL TORAUDE ET COMPAGNIE (FR) 1977-08-09 US claimed
US-4039549-A INHIBITS CNS TRANSMITTERS MERRELL TORAUDE ET COMPAGNIE (FR) 1977-08-02 US claimed
US-4010153-A Preparation of chiral 1,4-benzodiazepin-2-one-derivatives by reaction of (s)-α-amino acid chloride hydrochlorides etc. CRC COMPAGNIA DI RICERCA CHIMICA S.A. (CH) 1977-03-01 US claimed
US-3987040-A 3-SUBSTITUTED METHYL-7-ACYLAMINO-7-METHOXY-2-CEPHEM-4-CARBOXYLIC ACID AND ITS ESTERS MERCK & CO., INC. (US) 1976-10-19 US claimed
US-3980729-A PHENOLIC PREPOLYMER, SILANOL-CONDENSATION CATALYST AND A CURING CATALYST SHIN-ETSU CHEMICAL COMPANY LIMITED (JA) 1976-09-14 US claimed
US-3960927-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS RICHARDSON-MERRELL INC. (US) 1976-06-01 US claimed
US-3959356-A PHARMACOLOGY RICHARDSON-MERRELL INC. (US) 1976-05-25 US claimed
US-3934027-A 18β-Glycyrrhetinic acid amides useful as antiulcer agents PFIZER INC. (US) 1976-01-20 US claimed